Using two experimental anti-malarial vaccines, which work in different ways, can greatly reduce the number of malaria infections in animal studies.
Experimental vaccines, which independently achieve 48% and 68% reductions in malaria cases, can achieve 91% reduction when combined.
Presently, each vaccine is at a different stage of human trials, and there have not been efforts to combine them. However, a team led by Imperial College London have now tested the effectiveness when using the two types of vaccine together.
Reaching a potential 91% reduction in cases would have a huge impact on public health because the vaccines could be effective in areas where malaria is more prevalent.Dr Andrew Blagborough
The study, published today in the journal eLife, used genetically altered mouse parasites that express proteins expressed on the human version of the malaria parasite. The research was funded by the PATH’s Malaria Vaccine Initiative and the Medical Research Council (MRC), including researchers at Imperial’s MRC Centre for Outbreak Analysis and Modelling.
Lead researcher Dr Andrew Blagborough, from the Department of Life Sciences at Imperial, said: “This is the first direct evidence than combining vaccines of different types significantly improves their efficacy in terms of reducing malarial burden.
“Reaching a potential 91% reduction in cases would have a huge impact on public health because the vaccines could be effective in areas where malaria is more prevalent.”
Two types of vaccines
Malaria is caused by a group of parasites that have a complex life cycle, spending time in the mosquito midgut and salivary glands, in the human liver, and circulating in human blood, where they cause the disease.
The team tested two types of vaccines: those that prevent mosquitoes from transferring the parasites, called transmission-blocking vaccines (TBVs), and those that prevent the parasite from infecting the liver, termed pre-erythrocytic vaccines (PEVs).
RTS,S is the world’s first PEV malaria vaccine that has been shown to provide partial protection against malaria in young children by blocking infection of the liver. However, its maximum efficacy is under 50% (i.e. it reduces cases by around 50%).
There are currently several types of transmission-blocking vaccines in early trials, which are thought to reduce the number of parasites in the mosquito salivary glands. Their efficacy typically ranges from around 50-95%.
It has been assumed that combining these vaccines would increase their efficacy, but it has never been tested until now. The team found that when a partially effective PEV was combined with the most effective transmission-blocking vaccine, the efficacy was around 91%.
The team also found that combining any of the two types of vaccines improved efficacy of the mixture more than might be expected from the single efficacy of each vaccine separately.
Working towards elimination
Dr Morven Roberts, Programme Manager for parasites and neglected tropical diseases at the MRC, said: “While these findings are in the preliminary stages, they’re valuable as they shed light on optimising strategies for preventing malaria. Learning that combining vaccines can dramatically boost efficacy in mice provides another potential tactic for controlling this disease. This is timely research as global health officials work towards WHO targets to eliminate malaria by 2030.”
The team will next study how combined vaccines could work in more complex situations. Dr Blagborough said: “In the real world, the vaccine coverage we can achieve– how many people we can give it to – is important, as are the local levels of transmission, and how prevalent malaria currently is in that area.
“We plan to use a combination of rodent experiments and computer modelling to help us estimate effectiveness requirements for future vaccines.”
The efficacy of current lead malaria vaccines is known to reduce over time after vaccines are administered, so the team will also investigate how combined vaccines perform in the long term.
The Latest on: Malaria
via Google News
The Latest on: Malaria
- Malaria treatment: Is there a vaccine for Malaria? on September 19, 2018 at 1:49 am
MALARIA is currently plaguing the Indonesian tourist island of Lombok, where a recent earthquake devastated the country, paving the way for a potentially deadly Malaria outbreak. Is there a vaccine fo... […]
- Compound Prevents Malaria Transmission in Mosquitoes on September 18, 2018 at 11:45 pm
In a publication in Nature Communications, scientists from the Imperial College London have recently screened 70,000 compounds and were able to find just 6 of these compounds that are capable of stopp... […]
- To truly stop the spread of malaria, we might have to treat mosquitoes instead of ourselves on September 18, 2018 at 1:08 pm
Malaria is an incredibly devastating disease that regularly infects hundreds of millions of people every year, causing hundreds of thousands of deaths. In tropical areas, the disease runs rampant ... […]
- Malaria - A Drug Pipeline Analysis Report by Technavio on September 18, 2018 at 11:23 am
LONDON--(BUSINESS WIRE)--Technavio has announced their latest drug pipeline analysis report on malaria. The report includes a comprehensive research on the pipeline molecules under investigation by th... […]
- Drug compounds prevent mosquitoes' malaria infection on September 18, 2018 at 10:33 am
Sept. 18 (UPI) --Researchers have found six compounds that could prevent mosquitoes from being infected with malaria parasites as a way to stop the spread of the disease to humans. Around 70,000 compo... […]
- Administering Malaria Drugs to Mosquitoes on September 18, 2018 at 7:20 am
In a Disneyesque animated film, one could imagine thousands of anthropomorphized mosquitoes dressed in military fatigues waiting in long lines to be administered their antimalaria pills before they sh... […]
- Drugs that stop mosquitoes catching malaria could help eradicate the disease on September 18, 2018 at 6:42 am
A male malaria parasite sexual stage becoming active – a process called exflagellation that happens inside the mosquito stomach. Credit: Sabrina Yahiya Researchers have identified compounds that ... […]
- New compound could prevent malaria parasites from maturing inside mosquito on September 18, 2018 at 4:23 am
Researchers have identified compounds that could prevent malaria parasites from being able to infect mosquitoes, halting the spread of disease. Preventing transmission of malaria is a key part of effo... […]
- Indonesia's quake-hit Lombok declares health emergency over malaria on September 15, 2018 at 3:32 am
JAKARTA (Reuters) - Indonesia’s tourist island of Lombok is battling malaria, authorities said on Saturday, declaring a health emergency after a series of earthquakes in July and August forced ... […]
via Bing News